Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Devices

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Revenue projections:

Revenue projections for ZBH
Revenue projections for ZBH

Investors are expected to be cautious with ZBH, as its revenues are projected to fall compared to last year. A decline in revenue often results in a negative impact on profitability, prompting concerns about the company's financial stability and making investors more conservative in their approach.

Financial Ratios:

currentRatio 1.982000
forwardPE 10.279507
debtToEquity 61.971000
earningsGrowth -0.408000
revenueGrowth 0.109000
grossMargins 0.697080
operatingMargins 0.139670
trailingEps 3.550000
forwardEps 8.992650

ZBH's current ratio of 1.982, indicating that the company can meet its short-term debt obligations with ease. This high liquidity level is a positive sign, as ZBH has enough cash and current assets to handle its immediate liabilities comfortably.
ZBH's Forward PE is positioned well, reflecting a favorable balance between stock price and earnings. The stock isn't overpriced, offering room for growth and making it a potentially rewarding investment as its value has room to rise further.
ZBH's low growth in earnings and revenue indicates a potential decline in profits. This suggests that the company could be facing financial challenges, making it harder to sustain its current profit margins.
ZBH's negative gross and operating margins point to financial difficulties, as the company is unable to generate profit from its core operations or production. This could signal broader problems in cost management or declining sales.
ZBH's forward EPS is higher than its trailing EPS, suggesting the company is expected to improve its profitability this financial year. This reflects growing confidence in ZBH's earnings potential, with forecasts indicating better financial performance than in the prior year.

Price projections:

Price projections for ZBH
Price projections for ZBH

The stock price of ZBH has often been near the lower end of projections, indicating that it may not be meeting investor expectations. This trend could suggest challenges ahead for the company.

Insider Transactions:

Insider Transactions for ZBH
Insider Transactions for ZBH


There were 8 ZBH stock sales, with market price at 98.66490459442139.No sell transactions were completed during the period under review.With more buys than sells around ZBH's current price, there seems to be increased confidence among investors. This shift may indicate a favorable outlook, as the buying behavior suggests optimism for the stock's future growth or resilience.

Recommendation changes over time:

Recommendations trend for ZBH
Recommendations trend for ZBH


The recent buy bias for ZBH from analysts signals strong confidence in the stock's potential. This positive sentiment could encourage investors to see ZBH as a smart place to invest their money, especially those looking for stable, long-term returns in a well-established company.